Drug Development: Our portfolio of Tranlsational Platforms for Oncology and CVMD provide insight and understanding about a drug's efficacy, pharmacological profile and patient response profile, ...
Personal Genome Diagnostics (PGDx) is empowering the fight against cancer by unlocking actionable information from the genome. We are committed to developing a portfolio of regulated tissue-based ...
Systimmune Inc. is a bio-pharmaceutical company focused on the treatment of cancer through developing novel therapeutic bi-specific, and tri-specific antibodies, as well as antibody-drug ...
